MIRM - Mirum Pharmaceuticals Inc. (MIRM) CEO Chris Peetz on Q4 2021 Results - Earnings Call Transcript
Mirum Pharmaceuticals, Inc. (MIRM) Q4 2021 Earnings Conference Call March 9, 2022 16:30 ET Corporate Participants Ian Clements - Chief Financial Officer Chris Peetz - President, Chief Executive Officer Peter Radovich - Chief Operating Officer Pamela Vig - Chief Scientific Officer Ian Clements - Chief Financial Officer Conference Call Participants Jessica Fye - JPMorgan Mani Foroohar - SVB Leerink Ryan Deschner - Raymond James Ed Arce - H.C. Wainwright Josh Schimmer - Evercore Yasmeen Rahimi - Piper Sandler Presentation Operator Good afternoon and thank you for attending today's Mirum Pharmaceuticals fourth quarter business update call. My name is Amber and I will be moderator for today's call. [Operator Instructions]. It is now my pleasure to hand the conference over to our host, Ian Clements, CFO of Mirum Pharmaceuticals. Ian, please proceed. Ian Clements Thanks Amber and good afternoon everyone. I would like to welcome you to Mirum Pharmaceuticals fourth quarter
For further details see:
Mirum Pharmaceuticals, Inc. (MIRM) CEO Chris Peetz on Q4 2021 Results - Earnings Call Transcript